Abstract Pleomorphic sarcoma is an aggressive soft-tissue malignancy with heterogeneous metabolic characteristics and tumor biology. We herein report a 52-year-old woman with metastatic high-grade pleomorphic sarcoma who underwent dual-tracer imaging with [ 18 F]Fluorodeoxyglucose and [ 68 Ga]Ga-Fibroblast activation p...
M. Mali, S. Sonavane, Sandip Basu· World Journal of Nuclear Med...· 0 citations
Abstract 177 Lu-PSMA-617 targeted radioligand therapy (RLT) received U.S. Food and Drug Administration approval in 2022 for metastatic castration-resistant prostate cancer (mCRPC) patients progressing after androgen receptor pathway inhibitors and taxane chemotherapy. Despite its efficacy, response rates vary, promptin...
Amal Paul, Keerti Sitani, Sandip Basu· World Journal of Nuclear Med...· 0 citations
Seronegative autoimmune encephalitis (AIE) poses a significant diagnostic challenge because of the absence of identifiable neuronal antibodies and frequently normal structural neuroimaging. 18F-FDG PET/CT has emerged as a sensitive functional imaging modality for detecting metabolic abnormalities in such patients. We c...
Priyanka Verma, Keerti Sitani, Shilpa D. Kulkarni et al.· Journal of Nuclear Medicine...· 0 citations
False-positive findings on molecular imaging can pose significant diagnostic dilemmas in oncological cases. We report an elderly woman with metastatic neuroendocrine tumor of unknown primary who underwent 5 cycles of [177Lu]Lu-DOTATATE PRRT and achieved a partial response. On follow-up, [68Ga]Ga-DOTATATE and [18F]FDG-P...
INTRODUCTION
Thyroid cancer is the most common endocrine malignancy, and despite advances in understanding its genomic drivers, significant challenges remain in predicting tumor behavior, therapeutic response, and disease progression. This review summarizes advances in transcriptomic profiling and liquid biopsy approac...
Srabonti Ghosh, Avik Chakraborty, Bhakti Basu et al.· Expert Review of Anticancer...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.